Concepts (259)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Fetal Growth Retardation | 3 | 2018 | 217 | 1.60 | Why? |
| Placenta | 9 | 2021 | 1531 | 1.50 | Why? |
| Fetal Weight | 2 | 2019 | 24 | 0.94 | Why? |
| Pregnancy Complications | 6 | 2021 | 1388 | 0.93 | Why? |
| Pregnancy Outcome | 8 | 2021 | 3803 | 0.90 | Why? |
| Maternal Nutritional Physiological Phenomena | 2 | 2017 | 39 | 0.88 | Why? |
| Pre-Eclampsia | 3 | 2021 | 599 | 0.87 | Why? |
| Birth Weight | 3 | 2019 | 250 | 0.84 | Why? |
| Lasers, Gas | 1 | 2019 | 21 | 0.82 | Why? |
| Mastitis | 1 | 2019 | 27 | 0.80 | Why? |
| Vulvar Diseases | 1 | 2019 | 38 | 0.79 | Why? |
| Maternal Exposure | 3 | 2019 | 173 | 0.78 | Why? |
| Tetanus | 1 | 2019 | 61 | 0.76 | Why? |
| Fetofetal Transfusion | 1 | 2018 | 24 | 0.76 | Why? |
| Tamoxifen | 1 | 2019 | 83 | 0.76 | Why? |
| DNA, Mitochondrial | 2 | 2017 | 163 | 0.75 | Why? |
| Diphtheria | 1 | 2019 | 74 | 0.75 | Why? |
| DNA Fragmentation | 1 | 2018 | 67 | 0.74 | Why? |
| Lipid Mobilization | 1 | 2017 | 3 | 0.74 | Why? |
| Diphtheria-Tetanus-acellular Pertussis Vaccines | 1 | 2019 | 91 | 0.74 | Why? |
| Pregnancy | 35 | 2021 | 23879 | 0.73 | Why? |
| Twins, Monozygotic | 1 | 2018 | 83 | 0.72 | Why? |
| Diseases in Twins | 1 | 2018 | 86 | 0.70 | Why? |
| Postmenopause | 1 | 2019 | 160 | 0.70 | Why? |
| Placental Insufficiency | 1 | 2017 | 16 | 0.69 | Why? |
| Biological Factors | 1 | 2021 | 276 | 0.69 | Why? |
| Embryonic Development | 4 | 2018 | 55 | 0.69 | Why? |
| Carbon Monoxide | 1 | 2019 | 167 | 0.68 | Why? |
| Infant Nutritional Physiological Phenomena | 1 | 2017 | 75 | 0.64 | Why? |
| Pregnancy Complications, Infectious | 10 | 2021 | 11559 | 0.63 | Why? |
| Micronutrients | 2 | 2017 | 310 | 0.60 | Why? |
| Nitrogen Dioxide | 1 | 2019 | 488 | 0.60 | Why? |
| Spermatozoa | 1 | 2018 | 244 | 0.60 | Why? |
| Infectious Disease Transmission, Vertical | 5 | 2021 | 5164 | 0.58 | Why? |
| Energy Metabolism | 1 | 2017 | 451 | 0.51 | Why? |
| Breast Feeding | 3 | 2021 | 1585 | 0.50 | Why? |
| Antiretroviral Therapy, Highly Active | 1 | 2018 | 952 | 0.49 | Why? |
| Mitochondria | 2 | 2018 | 857 | 0.46 | Why? |
| DNA Methylation | 1 | 2017 | 688 | 0.46 | Why? |
| Serum Amyloid P-Component | 1 | 2012 | 193 | 0.43 | Why? |
| Delivery, Obstetric | 1 | 2020 | 1292 | 0.42 | Why? |
| Pregnant Women | 2 | 2021 | 2535 | 0.42 | Why? |
| Dietary Supplements | 3 | 2018 | 2251 | 0.41 | Why? |
| Obesity | 4 | 2018 | 7388 | 0.41 | Why? |
| Hospitals, Maternity | 2 | 2020 | 154 | 0.39 | Why? |
| Probiotics | 1 | 2017 | 694 | 0.38 | Why? |
| Patient Compliance | 2 | 2017 | 1468 | 0.36 | Why? |
| Infant, Newborn | 15 | 2021 | 23105 | 0.36 | Why? |
| Prenatal Care | 2 | 2017 | 1314 | 0.35 | Why? |
| Autoimmune Diseases | 1 | 2021 | 1996 | 0.34 | Why? |
| Italy | 16 | 2021 | 38444 | 0.34 | Why? |
| Hyperglycemia | 1 | 2018 | 1363 | 0.34 | Why? |
| Fetal Development | 2 | 2019 | 173 | 0.33 | Why? |
| Pregnancy Trimester, Third | 3 | 2020 | 445 | 0.32 | Why? |
| Prospective Studies | 15 | 2021 | 43301 | 0.29 | Why? |
| Vitamin D | 2 | 2018 | 2904 | 0.28 | Why? |
| Particulate Matter | 1 | 2017 | 3249 | 0.28 | Why? |
| Up-Regulation | 1 | 2012 | 2249 | 0.27 | Why? |
| Folic Acid | 2 | 2017 | 172 | 0.25 | Why? |
| HIV-1 | 1 | 2018 | 3365 | 0.25 | Why? |
| Air Pollutants | 2 | 2019 | 3110 | 0.25 | Why? |
| Female | 43 | 2021 | 380317 | 0.24 | Why? |
| Diabetes, Gestational | 2 | 2018 | 426 | 0.24 | Why? |
| Pregnancy Trimester, First | 3 | 2018 | 366 | 0.23 | Why? |
| HIV Infections | 5 | 2018 | 11620 | 0.22 | Why? |
| Fetal Blood | 2 | 2017 | 573 | 0.22 | Why? |
| Endothelium, Vascular | 1 | 2012 | 1751 | 0.22 | Why? |
| Adult | 30 | 2021 | 244371 | 0.21 | Why? |
| Body Mass Index | 3 | 2020 | 4306 | 0.20 | Why? |
| Homocysteine | 2 | 2017 | 83 | 0.20 | Why? |
| Premature Birth | 3 | 2021 | 2151 | 0.19 | Why? |
| Dimethylpolysiloxanes | 1 | 2018 | 46 | 0.19 | Why? |
| Vitamin B 12 | 2 | 2017 | 132 | 0.19 | Why? |
| Alpha-Globulins | 1 | 2018 | 18 | 0.19 | Why? |
| Oocyte Donation | 1 | 2018 | 17 | 0.19 | Why? |
| Urinary Incontinence, Stress | 1 | 2018 | 36 | 0.19 | Why? |
| Urethra | 1 | 2018 | 47 | 0.18 | Why? |
| Gestational Age | 3 | 2018 | 1488 | 0.18 | Why? |
| Air Pollution | 1 | 2017 | 3504 | 0.18 | Why? |
| Uterine Artery | 1 | 2018 | 36 | 0.18 | Why? |
| Sperm Injections, Intracytoplasmic | 1 | 2018 | 87 | 0.18 | Why? |
| Term Birth | 1 | 2017 | 56 | 0.17 | Why? |
| Discriminant Analysis | 1 | 2017 | 170 | 0.17 | Why? |
| Neonatal Abstinence Syndrome | 1 | 2017 | 15 | 0.17 | Why? |
| Uracil | 1 | 2017 | 101 | 0.17 | Why? |
| Vagina | 1 | 2020 | 327 | 0.17 | Why? |
| Semen Analysis | 1 | 2018 | 235 | 0.17 | Why? |
| Obstetric Labor, Premature | 1 | 2018 | 114 | 0.17 | Why? |
| Least-Squares Analysis | 1 | 2017 | 254 | 0.17 | Why? |
| Umbilical Arteries | 1 | 2017 | 62 | 0.17 | Why? |
| C-Reactive Protein | 2 | 2018 | 7972 | 0.17 | Why? |
| Hepcidins | 1 | 2017 | 97 | 0.16 | Why? |
| Case-Control Studies | 4 | 2021 | 17671 | 0.16 | Why? |
| Organ Size | 1 | 2017 | 384 | 0.16 | Why? |
| Periodontal Diseases | 1 | 2018 | 87 | 0.16 | Why? |
| Parity | 1 | 2017 | 122 | 0.16 | Why? |
| Ultrasonography, Prenatal | 5 | 2018 | 471 | 0.16 | Why? |
| Hydrophobic and Hydrophilic Interactions | 1 | 2017 | 382 | 0.15 | Why? |
| Humans | 47 | 2021 | 930598 | 0.15 | Why? |
| Atazanavir Sulfate | 1 | 2018 | 213 | 0.15 | Why? |
| Serotonin Uptake Inhibitors | 1 | 2017 | 149 | 0.15 | Why? |
| Reproductive Techniques, Assisted | 2 | 2017 | 400 | 0.14 | Why? |
| Infertility, Female | 1 | 2017 | 150 | 0.14 | Why? |
| Eating | 1 | 2018 | 395 | 0.14 | Why? |
| Diet | 2 | 2018 | 2052 | 0.14 | Why? |
| Anti-HIV Agents | 2 | 2018 | 2209 | 0.14 | Why? |
| Infant, Newborn, Diseases | 1 | 2019 | 394 | 0.14 | Why? |
| Carbon | 1 | 2017 | 269 | 0.14 | Why? |
| Magnesium | 1 | 2017 | 290 | 0.14 | Why? |
| Darunavir | 1 | 2018 | 477 | 0.14 | Why? |
| Nutritional Status | 2 | 2017 | 1403 | 0.13 | Why? |
| Crown-Rump Length | 3 | 2017 | 22 | 0.13 | Why? |
| Health Services Accessibility | 1 | 2017 | 10697 | 0.13 | Why? |
| Infertility | 1 | 2017 | 247 | 0.13 | Why? |
| Hydrogen-Ion Concentration | 1 | 2017 | 993 | 0.13 | Why? |
| Decidua | 1 | 2012 | 32 | 0.13 | Why? |
| Peritoneum | 1 | 2012 | 54 | 0.12 | Why? |
| Diet, Mediterranean | 1 | 2017 | 351 | 0.12 | Why? |
| Cesarean Section | 3 | 2021 | 2089 | 0.12 | Why? |
| Folic Acid Deficiency | 1 | 2012 | 22 | 0.12 | Why? |
| Prenatal Exposure Delayed Effects | 1 | 2017 | 319 | 0.12 | Why? |
| Methicillin-Resistant Staphylococcus aureus | 1 | 2019 | 711 | 0.12 | Why? |
| Staphylococcus aureus | 1 | 2019 | 844 | 0.12 | Why? |
| Depression, Postpartum | 1 | 2017 | 282 | 0.12 | Why? |
| Nutrition Policy | 2 | 2012 | 132 | 0.12 | Why? |
| Oxidative Stress | 3 | 2019 | 2050 | 0.12 | Why? |
| Amniocentesis | 1 | 2011 | 25 | 0.12 | Why? |
| Adolescent Development | 1 | 2012 | 55 | 0.12 | Why? |
| Mothers | 3 | 2017 | 1624 | 0.12 | Why? |
| Sexual Partners | 1 | 2017 | 612 | 0.12 | Why? |
| Calcium | 1 | 2017 | 708 | 0.11 | Why? |
| Metabolomics | 1 | 2017 | 921 | 0.11 | Why? |
| Women's Health | 1 | 2017 | 444 | 0.11 | Why? |
| Obstetrics | 1 | 2020 | 859 | 0.11 | Why? |
| Combined Modality Therapy | 1 | 2019 | 3395 | 0.10 | Why? |
| Pregnancy Trimester, Second | 1 | 2011 | 314 | 0.10 | Why? |
| Staphylococcal Infections | 1 | 2019 | 1099 | 0.10 | Why? |
| Meta-Analysis as Topic | 1 | 2017 | 1289 | 0.10 | Why? |
| Nutritional Requirements | 1 | 2010 | 115 | 0.10 | Why? |
| Infant | 5 | 2019 | 30274 | 0.10 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.09 | Why? |
| Vitamins | 1 | 2018 | 1208 | 0.09 | Why? |
| Young Adult | 10 | 2021 | 93724 | 0.09 | Why? |
| Patient Care | 1 | 2020 | 1664 | 0.09 | Why? |
| Motivation | 1 | 2019 | 1640 | 0.09 | Why? |
| Antibiotic Prophylaxis | 1 | 2011 | 399 | 0.09 | Why? |
| Adolescent | 10 | 2020 | 86841 | 0.09 | Why? |
| Ambulatory Care Facilities | 1 | 2020 | 2063 | 0.09 | Why? |
| MicroRNAs | 1 | 2021 | 1787 | 0.09 | Why? |
| Child Development | 1 | 2012 | 352 | 0.09 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.09 | Why? |
| Lactation | 1 | 2010 | 361 | 0.09 | Why? |
| Weight Gain | 1 | 2013 | 552 | 0.09 | Why? |
| Longitudinal Studies | 2 | 2021 | 9893 | 0.08 | Why? |
| Dyspnea | 1 | 2020 | 3847 | 0.08 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.08 | Why? |
| Middle Aged | 9 | 2020 | 270681 | 0.08 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.08 | Why? |
| Pilot Projects | 1 | 2017 | 5182 | 0.07 | Why? |
| Kidney Diseases | 1 | 2017 | 1434 | 0.07 | Why? |
| Health Care Rationing | 1 | 2020 | 2558 | 0.07 | Why? |
| Vitamin D Deficiency | 1 | 2018 | 1782 | 0.07 | Why? |
| Vascular Diseases | 1 | 2012 | 846 | 0.06 | Why? |
| Retrospective Studies | 3 | 2020 | 105322 | 0.06 | Why? |
| Fever | 1 | 2020 | 7795 | 0.06 | Why? |
| Kidney | 1 | 2017 | 3648 | 0.06 | Why? |
| Asymptomatic Infections | 1 | 2021 | 7218 | 0.06 | Why? |
| Developing Countries | 1 | 2017 | 4283 | 0.06 | Why? |
| Inflammation | 3 | 2020 | 13255 | 0.06 | Why? |
| Reference Values | 2 | 2017 | 795 | 0.05 | Why? |
| Elective Surgical Procedures | 1 | 2017 | 5338 | 0.05 | Why? |
| Biomarkers | 4 | 2018 | 23361 | 0.05 | Why? |
| Prevalence | 2 | 2018 | 25773 | 0.05 | Why? |
| Hypertension, Pregnancy-Induced | 1 | 2021 | 208 | 0.05 | Why? |
| Cervical Length Measurement | 1 | 2018 | 38 | 0.05 | Why? |
| Health Status | 1 | 2012 | 3259 | 0.05 | Why? |
| Olive Oil | 1 | 2018 | 46 | 0.05 | Why? |
| Pelvis | 1 | 2018 | 125 | 0.04 | Why? |
| Hypertension, Renal | 1 | 2017 | 9 | 0.04 | Why? |
| Pregnancy Trimesters | 1 | 2018 | 90 | 0.04 | Why? |
| Netherlands | 2 | 2017 | 3533 | 0.04 | Why? |
| Nephrons | 1 | 2017 | 18 | 0.04 | Why? |
| Seafood | 1 | 2018 | 103 | 0.04 | Why? |
| Fishes | 1 | 2018 | 99 | 0.04 | Why? |
| Pulsatile Flow | 1 | 2018 | 123 | 0.04 | Why? |
| Fertilization | 1 | 2017 | 49 | 0.04 | Why? |
| Ultrasonography, Doppler, Color | 1 | 2018 | 107 | 0.04 | Why? |
| Injections | 1 | 2018 | 237 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2019 | 10083 | 0.04 | Why? |
| Ovulation Induction | 1 | 2017 | 58 | 0.04 | Why? |
| Age Factors | 1 | 2018 | 21039 | 0.04 | Why? |
| Reoperation | 1 | 2018 | 544 | 0.04 | Why? |
| Infant, Low Birth Weight | 1 | 2017 | 243 | 0.04 | Why? |
| Male | 5 | 2020 | 367725 | 0.04 | Why? |
| Pharmacogenetics | 1 | 2017 | 222 | 0.04 | Why? |
| Hospitals, Special | 1 | 2020 | 523 | 0.04 | Why? |
| Triglycerides | 1 | 2018 | 478 | 0.04 | Why? |
| Meat | 1 | 2018 | 380 | 0.04 | Why? |
| Morbidity | 1 | 2021 | 1426 | 0.04 | Why? |
| Bilirubin | 1 | 2018 | 503 | 0.04 | Why? |
| Consensus | 2 | 2021 | 6345 | 0.03 | Why? |
| Risk Factors | 2 | 2021 | 71621 | 0.03 | Why? |
| Personal Autonomy | 1 | 2017 | 313 | 0.03 | Why? |
| Vaccination | 1 | 2019 | 19050 | 0.03 | Why? |
| Cholesterol | 1 | 2018 | 660 | 0.03 | Why? |
| Cohort Studies | 4 | 2018 | 36005 | 0.03 | Why? |
| Societies, Medical | 2 | 2021 | 6907 | 0.03 | Why? |
| Fertility | 1 | 2017 | 367 | 0.03 | Why? |
| Treatment Failure | 1 | 2018 | 2106 | 0.03 | Why? |
| Parturition | 1 | 2017 | 514 | 0.03 | Why? |
| Hospitals, Teaching | 1 | 2020 | 1609 | 0.03 | Why? |
| Predictive Value of Tests | 2 | 2018 | 9537 | 0.03 | Why? |
| Cross-Sectional Studies | 1 | 2019 | 53120 | 0.03 | Why? |
| Infant, Premature | 1 | 2017 | 883 | 0.03 | Why? |
| Alanine Transaminase | 1 | 2018 | 1329 | 0.03 | Why? |
| Imaging, Three-Dimensional | 1 | 2017 | 680 | 0.03 | Why? |
| Follow-Up Studies | 2 | 2021 | 17020 | 0.03 | Why? |
| Self Efficacy | 1 | 2017 | 717 | 0.03 | Why? |
| Pandemics | 5 | 2020 | 389249 | 0.03 | Why? |
| Mental Health | 1 | 2017 | 15770 | 0.03 | Why? |
| Psychiatric Status Rating Scales | 1 | 2017 | 1340 | 0.03 | Why? |
| Taste Disorders | 1 | 2020 | 1720 | 0.02 | Why? |
| Pre-Exposure Prophylaxis | 1 | 2017 | 1138 | 0.02 | Why? |
| Transcriptome | 1 | 2021 | 3466 | 0.02 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 1 | 2018 | 1261 | 0.02 | Why? |
| Asymptomatic Diseases | 1 | 2020 | 3444 | 0.02 | Why? |
| Health Promotion | 2 | 2012 | 2020 | 0.02 | Why? |
| Survival Rate | 1 | 2021 | 9206 | 0.02 | Why? |
| European Union | 1 | 2010 | 565 | 0.02 | Why? |
| Depressive Disorder | 1 | 2017 | 1236 | 0.02 | Why? |
| Odds Ratio | 1 | 2017 | 5861 | 0.02 | Why? |
| Evidence-Based Practice | 1 | 2010 | 693 | 0.02 | Why? |
| Severity of Illness Index | 1 | 2012 | 48226 | 0.02 | Why? |
| Child | 3 | 2021 | 70012 | 0.02 | Why? |
| Clinical Competence | 1 | 2018 | 3263 | 0.02 | Why? |
| Social Support | 1 | 2017 | 3183 | 0.01 | Why? |
| Saliva | 1 | 2018 | 4679 | 0.01 | Why? |
| Surveys and Questionnaires | 2 | 2020 | 43792 | 0.01 | Why? |
| Child, Preschool | 2 | 2018 | 36283 | 0.01 | Why? |
| Triage | 1 | 2020 | 7151 | 0.01 | Why? |
| Nasopharynx | 1 | 2020 | 10224 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.01 | Why? |
| Population Surveillance | 1 | 2017 | 4967 | 0.01 | Why? |
| Tertiary Care Centers | 1 | 2017 | 8248 | 0.01 | Why? |
| Genome, Viral | 1 | 2020 | 13157 | 0.01 | Why? |
| Global Health | 1 | 2021 | 13911 | 0.01 | Why? |
| Viral Load | 1 | 2018 | 15850 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2018 | 22971 | 0.01 | Why? |
| Acute Kidney Injury | 1 | 2017 | 5762 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.01 | Why? |
| Time Factors | 1 | 2018 | 31397 | 0.01 | Why? |
| Prognosis | 1 | 2017 | 32490 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2012 | 10649 | 0.01 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.01 | Why? |
| Treatment Outcome | 1 | 2018 | 51732 | 0.01 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.01 | Why? |
| Animals | 1 | 2018 | 78931 | 0.01 | Why? |
| Antibodies, Viral | 1 | 2020 | 51949 | 0.01 | Why? |
| Aged | 1 | 2018 | 215776 | 0.00 | Why? |